Multiple Endocrine Neoplasia Type 2 Syndromes: Nomenclature Recommendations from the Workshop Organizing Committee by Gagel, Robert F. et al.
Henry Ford Hospital Medical Journal 
Volume 37 Number 3 Article 3 
9-1989 
Multiple Endocrine Neoplasia Type 2 Syndromes: Nomenclature 
Recommendations from the Workshop Organizing Committee 
Robert F. Gagel 
Charles E. Jackson 
Bruce A. J. Ponder 
Friedhelm Raue 
Nancy E. Simpson 
See next page for additional authors 
Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal 
 Part of the Life Sciences Commons, Medical Specialties Commons, and the Public Health Commons 
Recommended Citation 
Gagel, Robert F.; Jackson, Charles E.; Ponder, Bruce A. J.; Raue, Friedhelm; Simpson, Nancy E.; and Ziegler, 
Reinhard (1989) "Multiple Endocrine Neoplasia Type 2 Syndromes: Nomenclature Recommendations 
from the Workshop Organizing Committee," Henry Ford Hospital Medical Journal : Vol. 37 : No. 3 , 99. 
Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol37/iss3/3 
This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has 
been accepted for inclusion in Henry Ford Hospital Medical Journal by an authorized editor of Henry Ford Health 
System Scholarly Commons. 
Multiple Endocrine Neoplasia Type 2 Syndromes: Nomenclature 
Recommendations from the Workshop Organizing Committee 
Authors 
Robert F. Gagel, Charles E. Jackson, Bruce A. J. Ponder, Friedhelm Raue, Nancy E. Simpson, and Reinhard 
Ziegler 
This article is available in Henry Ford Hospital Medical Journal: https://scholarlycommons.henryford.com/
hfhmedjournal/vol37/iss3/3 
Multiple Endocrine Neoplasia Type 2 Syndromes: Nomenclature 
Recommendations from the Workshop Organizing Committee 
Robert F. Gagel,* Charles E . Jackson,' Bruce A.J. Ponder,* Friedhelm Raue,^  
Nancy E . Simpson ,11 and Reinhard Ziegler^ 
F or this issue of the Journal and as a recommendation to other authors and journals for uniformity of preferred nomen-
clature, the following suggestions were made; 
MTC Medullary thyroid cancer or carcinoma, to be used 
for consistency rather than MCT, The two types of 
MTC are hereditary and nonhereditary. 
MEN 2 The multiple endocrine neoplasia type 2 syndromes 
{not MEA, MEN-II, MEN-2, or M.E,N. 2). 
MEN 2A The MEN 2 syndrome without the mucosal neu-
roma phenotype (not MEN 2a). 
MEN 2B The MEN 2 syndrome with the mucosal neuroma 
phenotype (not MEN 2b). This has also been re-
ferred to as MEN 3. 
MEN2A The designation of the mutated gene causing MEN 
2A. As recommended by the 1989 Human Gene 
Mapping conference (I), gene designations are no 
longer italicized or underlined. 
MEN2B The designation of the mutated gene causing MEN 
2B. 
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